scholarly journals Untreated urinary bladder stone and subsequent squamous cell carcinoma

2019 ◽  
Vol 30 (1) ◽  
pp. 40
Author(s):  
Marcelo Chen ◽  
Jen-Shu Tseng ◽  
Wen-Chou Lin
2021 ◽  
Vol 79 ◽  
pp. 379-385
Author(s):  
Septa Surya Wahyudi ◽  
Achmad Romy Syahrial Rozidi ◽  
Rahmat Sayyid Zharfan ◽  
Dewi Setyowati

2006 ◽  
Vol 22 (4) ◽  
pp. 372
Author(s):  
Tanmaya Goel ◽  
Sreedhar Reddy ◽  
Joseph Thomas ◽  
Shveta Garg

2018 ◽  
Vol 74 (4) ◽  
pp. 529-531 ◽  
Author(s):  
Aaron M. Udager ◽  
Andrew S. McDaniel ◽  
Daniel H. Hovelson ◽  
Kristina Fields ◽  
Simpa S. Salami ◽  
...  

2000 ◽  
Vol 124 (3) ◽  
pp. 455-459
Author(s):  
Funda Vakar-López ◽  
Jacki Abrams

Abstract Basaloid squamous cell carcinoma is a recently described, distinct variant of squamous cell carcinoma that arises predominantly in the upper aerodigestive tract. Herein we report a case of basaloid squamous cell carcinoma arising in the urinary bladder. The patient was a 60-year-old woman who experienced intractable urinary tract infections following multiple corrective surgical procedures for incontinence. Biopsies of cystoscopically evident flat lesions were performed, and the patient subsequently underwent a radical cystectomy. Histologically, the lesions consisted of nests of basaloid cells with brisk mitotic activity, areas of squamous differentiation along with areas of squamous metaplasia, and squamous cell carcinoma in situ. These features are similar to those of basaloid squamous cell carcinoma described elsewhere in the body. To our knowledge, this is the first reported case of basaloid squamous cell carcinoma in the urinary bladder.


2020 ◽  
Vol 9 (2) ◽  
pp. 428-436
Author(s):  
Zhenhua Liu ◽  
Yisen Meng ◽  
Yudong Cao ◽  
Yuke Chen ◽  
Yu Fan ◽  
...  

2003 ◽  
Vol 18 (4) ◽  
pp. 284-289 ◽  
Author(s):  
A. El-Meghawry El-Kenawy ◽  
A.F. El-Kott ◽  
A.M. Khalil

The aim of this study was to elucidate the associations between immunostaining for MDM2 and p53, their respective expression in squamous cell carcinoma of the urinary bladder, and the value of these variables for predicting treatment outcome after cystectomy. Inactivation of TP53 might play a role in the development and progression of bladder cancer. Complex formation with the MDM2 product is one mechanism that inactivates the p53 protein. Therefore, the MDM2 and the p53 protein were investigated to study potential interactions in bladder cancer. Fifty archival bladder tissue specimens were immunohistochemically stained using monoclonal antibodies against p53 and MDM2. Staining for p53 was observed in 48% of the specimens and staining for MDM2 in 20%. Univariate analysis demonstrated a significant correlation between p53 accumulation and survival (p=0.0101), while the correlation between MDM2 and survival was not significant (p=0.7183). The combined expression of MDM2 and p53 doest not add to the prognostic information provided by p53 alone.


Sign in / Sign up

Export Citation Format

Share Document